|
HS Code |
178379 |
| Chemicalname | Tert-Butyl 2,2,2-Trichloroacetimidate |
| Casnumber | 77381-36-9 |
| Molecularformula | C6H10Cl3NO |
| Molecularweight | 218.51 |
| Appearance | Colorless to pale yellow liquid |
| Boilingpoint | 94-95°C at 10 mmHg |
| Density | 1.23 g/mL at 25°C |
| Purity | Typically ≥97% |
| Solubility | Soluble in common organic solvents (e.g., dichloromethane, ether) |
| Refractiveindex | n20/D 1.458 |
| Storagecondition | Store at 2-8°C, protect from moisture |
| Smiles | CC(C)(C)OC(=N)C(Cl)(Cl)Cl |
As an accredited Tert-Butyl 2,2,2-Trichloroacetimidate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 25g amber glass bottle with a secure screw cap, labeled "Tert-Butyl 2,2,2-Trichloroacetimidate," including hazard and handling information. |
| Shipping | Tert-Butyl 2,2,2-Trichloroacetimidate is shipped as a hazardous chemical under cool, dry, and well-ventilated conditions. It must be contained in tightly sealed, chemical-resistant packaging to prevent moisture and contamination. Proper labeling and documentation are required, and handling should comply with all relevant transport and safety regulations. |
| Storage | Tert-Butyl 2,2,2-Trichloroacetimidate should be stored in a tightly sealed container, protected from moisture and light. Keep it in a cool, dry, and well-ventilated area, ideally under an inert atmosphere such as nitrogen. Store away from strong acids, bases, and oxidizing agents to prevent decomposition. Ensure proper labeling and comply with relevant safety regulations for chemical storage. |
Applications of Tert-Butyl 2,2,2-Trichloroacetimidate in Industrial ManufacturingAs a manufacturer specializing in Tert-Butyl 2,2,2-Trichloroacetimidate, we supply this reagent for specialized synthesis steps in advanced organic chemistry. Its primary utility centers on downstream transformations in pharmaceutical APIs, custom fine chemicals, and agrochemical intermediates production. The following sections detail established, industrial-scale applications based on actual usage in compliant manufacturing environments. 1. Pharmaceutical Glycosylation ReactionsThis raw material enables specific glycosylation steps for the synthesis of glycosides and oligosaccharide-based drug substances. Its high reactivity toward alcohols under mild acid catalysis supports the precise coupling of sugar moieties, a crucial step in creating bioactive compounds and prodrugs. Controlled addition at the activation stage helps manufacturers achieve targeted product purity and yield. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Synthesis of Protected Hydroxyl Compounds (Tert-Butyl Ethers)The material acts as a highly selective tert-butyl etherification agent in the synthesis of protected alcohols. This step is critical for multi-stage organic synthesis when hydroxyl groups must be masked to prevent side reactions. Its application ensures effective yield in producing intermediates for APIs, without introducing metal impurities or impacting downstream deprotection chemistry. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Agrochemical Intermediate SynthesisIn the agrochemical sector, Tert-Butyl 2,2,2-Trichloroacetimidate helps construct protected alcohol intermediates essential for producing crop protection actives. The reagent ensures chemoselective protection, allowing for subsequent halogenation, nitration, or alkylation with minimal side reactions. This integration supports the high-throughput synthesis routes required by major agrochemical producers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Custom Synthesis of Carbohydrate Derivatives for Biomedical ResearchContract research and specialty synthesis firms employ Tert-Butyl 2,2,2-Trichloroacetimidate to produce specialty carbohydrate derivatives used in diagnostics, vaccine development, and novel therapeutic platforms. The selectivity profile supports the construction of complex glycan arrays and bioconjugates by allowing precise control over reaction sites and facilitating the introduction of diverse functional groups. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Scale-up Synthesis of Nucleoside Analog IntermediatesTert-Butyl 2,2,2-Trichloroacetimidate finds regular application in the industrial assembly of protected nucleoside intermediates, supporting large-volume processes in antiviral and oncological pharmaceutical lines. The material delivers reproducible selectivity for hydroxyl protection, crucial for achieving process consistency during multiple-stage syntheses. Large-scale users value the minimal by-product profile and the established workup protocols for downstream catalytic steps. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Tert-Butyl 2,2,2-Trichloroacetimidate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a chemical manufacturer rooted in hands-on daily processing, we see firsthand how slight tweaks in molecular structure can make or break a reaction. Years of engineering and analytical experience have shaped our understanding of how reagents like tert-Butyl 2,2,2-trichloroacetimidate perform under varying synthesis conditions. Our facility, designed for seamless transitions between small batches and ton-scale processes, focuses on purity, consistency, and realistic timelines. The journey of this molecule starts not in the abstract, but in the precise handling of volatile trichloroacetonitrile, advanced distillation, and strict atmosphere control. Through experience, our team discovered that even the glassware and sequence of reagent addition play critical roles in yield and performance.
With the molecular formula C6H10Cl3NO, tert-Butyl 2,2,2-trichloroacetimidate offers chemists a specific blend of reactivity and selectivity. We produce this compound using high-purity starting materials in a temperature-controlled environment, avoiding side reactions that introduce byproducts. Our standard model delivers a product with a minimum assay of 98% by GC, free-flowing, and crystal clear. From reaction vessel selection to the final crystallization, our protocols avoid ambiguous batch-to-batch variations.
Our specification sheets reflect hard-won insights: water content below 0.5%, residual solvents below trace detection by GC-MS, and a melting range tightly controlled, offering reproducibility in challenging applications. We package under inert nitrogen in amber glass containers. Over time we learned that exposure to humidity during packaging drastically reduces storage time and shifts melting points, so our staff consistently works in dehumidified, strictly monitored environments. These measures originated from repeated trials, customer feedback, and the need to meet the stringent requirements of medicinal chemistry projects.
Few reagents accelerate transformations quite like this imidate. We supply it mainly to labs focused on glycosylation, where it activates hydroxyl groups for efficient formation of glycosidic bonds. This role as an O-glycosylation promoter has become its central use. Our customers send us feedback from carbohydrate synthesis teams, peptide chemistry groups, and researchers working in protected group manipulations. They find the tert-butyl group brings stability without the harshness of methyl or ethyl analogues, minimizing unwanted rearrangements. Over years of customer interaction, we tracked the subtle differences in reactivity against structurally similar imidates and acetimidates, building a broader knowledge base than catalog entries can ever provide.
In our own development lab, we tried dozens of methods using closely related trichloroacetimidates. Many oxidized or decomposed in the presence of mild acid, while tert-butyl derivatives withstood brief exposures to ambient moisture and handled typical protocols for regioselective glycosylation. This reliability has become a selling point in our internal process lists, as well as in recommendations to outside researchers. Practical challenges, like scale-up to a 50-liter batch without runaway exotherms, forced us to refine our cooling ramp and run continuous real-time spectroscopic analysis on production samples. These changes did not come from a textbook but from production blunders and corrective action on the floor.
Colleagues at other companies sometimes favor methyl or ethyl 2,2,2-trichloroacetimidate because of cost or availability. Our firsthand trials revealed that these alternatives give diminished selectivity and shorter shelf life, especially when run in open reactors or with unfiltered solvents. The tert-butyl variant stands out because of its optimal balance between activation and stability, a property noticed most clearly in multi-step syntheses desiring high overall yield. Peptide chemists have singled out our material as offering less background reactivity than smaller analogues—feedback echoed by repeated blind experiments in both our QC lab and external partner sites.
The extra bulk of the tert-butyl group, combined with the electron-withdrawing effects of the trichloromethyl side, changes how the imidate behaves in condensed-phase reactions. Our team spent weeks running direct comparisons, charting everything from reaction times to the ease of post-reaction cleanup. In cases where methyl analogues left behind stubborn residues, our product allowed for cleaner filtrations and reduced the formation of side-chain adducts. These facts matter in any lab keen on time and solvent savings.
One challenge in carbohydrate chemistry lies in ensuring that glycosyl donors and acceptors react cleanly, without double bonds shifting or protecting groups hydrolyzing. Over dozens of customer stories—ranging from research hospitals to international biotech firms—our compound led to sharper glycosylation peaks and improved overall reaction profiles. While reviewing an especially tough synthesis for an immunogenic oligosaccharide, our technician noted that substituting methyl imidate with tert-butyl 2,2,2-trichloroacetimidate reduced byproduct formation by almost half. Further internal data indicated that this difference resulted not just from inherent chemical properties, but also from the strict standards we apply in our own process control, such as triple-filtration for particulate removal pre-crystallization.
These lessons came not from abstract theorizing, but from blunted yields, fouled chromatography columns, and the extra hours we spent purifying products during earlier years. Listening to partner labs helped us pinpoint that our product’s stability under neutral and weakly acidic conditions conferred a real advantage. We continue to refine how we dry and store the compound, based on lessons in minimizing vapor losses and bottle leaching.
Chemical stability is always a front-line concern. Our internal shelf-life monitoring showed dramatic swings in purity if the compound spent prolonged periods at room humidity, regardless of the original batch quality. We responded by developing low-humidity, vacuum-sealed storage and by advising clients to chill stocks below 4°C whenever possible. More than one client reported extended shelf life and higher yields after switching to our nitrogen-purged packaging, a change prompted by our own mishaps with moisture ingress leading to hydrolyzed material during humid summers.
Logistics teams sometimes underestimated the sensitivity. Quick adaptation included tamper-evident seals and real-time tracking to monitor temperature and pressure during shipping. This stems not from marketing trends, but from cargo inspections leading to repackaging when off-spec conditions arose. We regard feedback on smell, physical appearance, or even skepticism about purity as data to improve, and our analytical chemists follow up with live support, not automated responses.
We do not rely solely on HPLC data or IR spectra; instead, we cross-check batches with standard NMR as part of release protocols, confirmed against samples from historical lots to verify consistency. Each improvement resulted from a specific challenge, often highlighted by a persistent customer or our own QC teams spotting subtle shifts between monthly productions.
Every synthetic challenge starts with a conversation between our technical chemists and the end-user. Our specialty customers—those at the front edge of complex oligosaccharide or protected alcohol chemistry—often come with tough questions. Some require input on adapting reaction conditions for scale-up. Our lab staff builds on recorded experiments and, when necessary, tries new solvent exchange techniques or reactivity modifiers to unlock better results. In a recent inquiry, a team needed a batch variant with lowered water content for a sensitive pharmaceutical precursor. Our operators responded by scheduling a triple vacuum-drying sequence and pulled a higher-purity lot than the project had seen in six prior attempts.
Improved customer outcomes come from honest conversations about practical limits, including shelf-life expectations, with zero sugar coating. We do not pretend to eliminate all process hiccups, but instead use each failed batch or rejected lot as a teaching instrument. This approach saved a biotech startup weeks of sifting through apparent reaction failures, only for the root cause to be traced to old stock sent from another supplier. Our replacement batch completed the glycosylation without acid-catalyzed breakdown that hampered their trials.
With over a decade of process improvement behind us, we see how small chemical tricks become decisive. While tert-butyl 2,2,2-trichloroacetimidate costs more to synthesize and purify than many standard reagents, its pay-off materializes in smoother workups, higher reproducibility, and cleaner end products. One of our process engineers tracked the use of various imidates over multi-year research projects and saw fewer failed endpoints, translating into fewer wasted laboratory hours and faster-to-market candidates.
This isn’t just about yield. Clean isolations and manufacturing predictability matter. In scale-up projects for carbohydrate-based vaccines or synthetic glycosides, regulatory agencies demand not only purity but also reliability batch after batch. Here, our manufacturing records, archived under strict GxP protocols, support traceability back to the earliest pilot experiments. We keep detailed logs of every batch processed—a necessity discovered after an early customer attempted a scale-up that revealed a minor fluctuation in reagent concentration between lots. Working together, we aligned on a process review, tightened batch audit checkpoints, and avoided regulatory setbacks.
Chemical reagents often seem interchangeable on paper, but real-world experience uncovers their unique quirks. For years, process failures from improper moisture control, temperature spikes, or misjudged storage protocols affected yields across the industry. Drawing on repeated process audits and equipment upgrades, we now tightly couple our analytical labs with production scheduling. Real-time adjustments catch shifts before they cascade into off-spec shipments.
Customer laboratories taught us to expect wide variance in solvent quality, reaction glassware, or environmental controls, especially outside of pharma manufacturing. We learned to offer clear, direct recommendations—keep our imidate cold, dry, and tightly sealed for best results, and always check the actual batch QC report, not just a generic data summary. We offer real human support and follow-up, not generalized scripts.
Addressing disposal questions, we actively engage with environmental officers at customer sites. Our spill and neutralization procedures reflect both regulatory standards and field incidents reported back to us from years in chemical manufacturing. Practical training—like hands-on drills with production staff—minimize error and downtime, cutting the frequency of batch recalls or product returns.
Consistent growth comes from humility. In-house chemists learn more from a batch gone slightly wrong than a hundred textbook runs. We log every deviation and revisit failures during monthly production meetings. These become case studies guiding our formulation tweaks and upgrades to equipment. New filtration membranes, improved argon blanketing, and process chemist-led brainstorming meetings all come from our drive to offer better, safer, more predictable solutions for users of tert-butyl 2,2,2-trichloroacetimidate.
Having worked personally in production rooms documenting everything from early color changes to post-filtration residue, our commitment builds from actual experience, not catalogue requirements. Technicians and chemists collaborate daily, cross-checking every sample and debating best practices openly. This culture yields tangible improvements to product quality and end-user satisfaction.
Manufacturing tert-butyl 2,2,2-trichloroacetimidate a hundred times over, under changing weather, power fluctuations, and evolving regulatory scrutiny, shows us both its power and its limits. Careful handling, real attention to feedback, and a willingness to adjust processes pay off in long-term relationships and dependable results for clients in research and industry. We share what we learn from every customer, every batch, and every setback, aiming not just for sales, but for shared technical progress. Our team stands behind every shipment, ready to troubleshoot, adapt, and improve with every challenge that comes through the door.